XERS icon

Xeris Biopharma Holdings

50 hedge funds and large institutions have $193M invested in Xeris Biopharma Holdings in 2019 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 8 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$11.4M
2 +$4.77M
3 +$3.98M
4
State Street
State Street
Massachusetts
+$2.1M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$929K

Top Sellers

1 -$1.21M
2 -$1M
3 -$753K
4
Morgan Stanley
Morgan Stanley
New York
-$603K
5
EGM
Engineers Gate Manager
New York
-$425K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$204K
27
$198K
28
$197K
29
$197K
30
$194K
31
$169K
32
$161K
33
$161K
34
$118K
35
$115K
36
$115K
37
$103K
38
$79K
39
$68K
40
$48K
41
$42K
42
$26.5K
43
$26K
44
$25.3K
45
$19K
46
$9K
47
$6K
48
$4K
49
$3K
50
$2K